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Purpose: IRF-5 is a direct transducer of virus-mediated and
TLR-mediated signaling pathways for the expression of cytokines
and chemokines which form homodimers or heterodimers with
IRF-7. However, direct IRF-5-specific monoclonal antibodies
(mAbs) are not available at present. These could be used to
further evaluate the functions of IRF-5. In this study, we
produced and characterized three mouse mAbs to human
IRF-5. The binding of IRF-5 to nuclear import proteins was
first identified using a mAb. Materials and Methods: His-
tagged human IRF-5 protein spanning amino acid residues 193-
257 was used as an antigen and three mAbs were produced.
The mAbs were tested with ELISA, Western blot analysis
(WB), immunofluorescent staining (IF), and immunoprecipi-
tation (IP). In addition, the nuclear import protein which
carried phosphorylated IRF-5 was identified using one of these
mAbs. Results: MAbs 5IRF8, 5IRF10 and 5IRF24 which
reacted with the recombinant His-IRF-5
193-257 protein were
produced. All mAbs bound to human IRF-5, but not to IRF-3
or IRF-7. They could be used for WB, IF, and IP studies. The
binding of phosphorylated IRF-5 to karyopherin- 1 and - 1 α β
was also identified. Conclusion: Human IRF-5-specific mAbs
are produced for studying the immunologic roles related to
IRF-5. Phosphorylated IRF-5 is transported to the nucleus by
binding to nuclear import proteins karyopherin- 1 and - 1. α β
Key Words: Human IRF-5, monoclonal antibody, nuclear
import protein, karyopherins
INTRODUCTION
After first identifying interferon-regulatory
factor 1 (IRF-1), nine additional IRF family proteins
have been identified. IRF-1 binds to elements in
the gene promoter that encodes for interferon-β
(IFN- ). β
1 Extensive studies of IRF family of pro-
teins have revealed that they are involved in regu-
lating virus-IFN axis, antigen presentation, nitric
oxide production, and the cell cycle.
2,3 The IRF
family of proteins also has an important role in the
innate immune system, and the secondary response
to cytokines. The signaling of toll-like receptors
(TLRs) triggered by microbial components is
important to the activation of innate and adaptive
immune responses. For example, TLR-4 activation
recruits the downstream adaptor molecule MyD88
and other signaling molecules for initial responses.
IRF-3 and IRF-7 then interact with MyD88 and
induce type I IFNs. In contrast, IRF-4 competes
with IRF-5 and acts as a negative regulator for TLR
signaling of the MyD88 interaction.
4 This suggests
that there are complex regulatory mechanisms
involved in MyD88 signaling. IRF-3 and IRF-7
function as direct transducers of virus-mediated
signaling, and play a crucial role in the expression
of type I IFN.
5-9
IRF-5 is a recently characterized member of the
IRF family. It encodes a ~61-kDa protein which
was originally identified as a regulator of type I
IFN gene expression.
10 Recent studies have indi-
cated that it plays a role in host defense, including
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the induction of multiple cytokines.
11 Similar to
IRF-3 and IRF-7, IRF-5 is a direct transducer of
virus-mediated signaling. However, this only
occurs with specific viruses such as the Newcastle
disease virus, vesiculostomatitis virus, and herpes
simplex type 1 virus.
10,12 It also plays a role in the
expression of cytokines and chemokines.
10,12,13 IRF-
5 is a direct target of p53. Its expression is modu-
lated by p53,
14 and it has a role in the p53-indepen-
dent proapoptotic signaling pathway.
15,16 Recent
studies have reported the association between
IRF-5 and systemic lupus erythematosus.
17,18 In a
gene chip study using overexpressed B cells which
contained IRF-5 or IRF-7, the presence of IRF-5 was
related to a strong immune response and adhesion
genes. The presence of IRF-7, however, selectively
upregulated the expression of mitochondrial genes
and DNA repair genes.
19 This suggests a distinct
role for IRF-5. The IRF family of proteins resides
in the cytoplasm of resting cells. They are activated
by phosphorylation on the C terminus, and are
transported to the nucleus after homo- or hetero-
dimerization.
10,13 IRF-5 dimerizes either with itself
or with IRF-3, and activates IFNA gene transcrip-
tion.
10,13 However, the heterodimerization of IRF-5
with IRF-7 represses IFNA transcription in virus-
infected cells which were cotransfected with IRF-5
and IRF-7.
10,13 Recently, IRF-5 was found to have
an important role in TLR signaling and the
induction of proinflammatory cytokines such as
interleukin (IL)-6, IL-12, and tumor necrosis factor
(TNF)- . It is impaired in cells from IRF-5-deficient α
mice,
11 suggesting that IRF-5 is generally involved
downstream of the TLR signaling pathway. IRF-5
associates with both MyD88 and TRAF-6, and is
translocated to the nucleus in a MyD88-dependent
fashion.
11 However, many of the downstream
mediators of the IRF-5 pathway need further iden-
tification.
The proteins in the KAP family act as shuttling
receptors. They bind to the NLS motifs of cargo
proteins to facilitate their import into the nucleus.
20
IRF-5 is phosphorylated by the stimulation of type
I interferon and viral infections. It then enters the
nucleus to regulate transcription.
10,12 IRF-5 has two
nuclear localization signals (NLSs). These are
found at residues 46 to 52 on a DNA binding
domain, and on residues 448 to 454 on a transac-
tivation domain. There is also one nuclear export
signal (NES) on residues 150 to 160.
12,21 This
implies its tight control of nuclear transport. IRF-5
is localized to the cytoplasm in an unstimulated
state. It moves to the cytoplasm in a CRM1-
dependent pathway after it is dephosphorylated in
the nucleus.
21
In this study we developed and characterized
monoclonal antibodies (mAbs) to the human IRF-5
protein and tested their applicability of IRF-5-
specific mAbs. Our mAbs were found to bind to
human IRF-5, but not to human IRF-3 or IRF-7. We
demonstrated the usefulness of these mAbs in
Western blot, immunocytochemical, and immuno-
precipitation analyses, as well as the import of
IRF-5 to the nucleus. In addition, it was identified
that IRF-5 is transported into the nucleus with the
aid of the carrier proteins karyopherin (KAP)- 1 α
and - 1. β
MATERIALS AND METHODS
Cell cultures and transfection
The human macrophage line THP-1, the human
embryonic kidney cell line HEK293 (ATCC), and
NIH3T3 cells were cultured. The culture was done
at 37 C under 5% CO2 in RPMI1640 supplemented
with 10% FBS (Invitrogen Life Technologies, San
Diego, CA, USA), 100 U/mL penicillin, 100 g/ μ
mL streptomycin, and 2 mM L-glutamine. For the
transient transfection, FuGene6 (Roche Diagno-
stics GmbH, Mannheim, Germany) was used for
the HA-tagged human IRF-3, HA-tagged IRF-5,
GFP-tagged IRF-5, and Flag-tagged IRF-7 expres-
sions.
DNA constructs and protein purification
We cloned the gene which encodes six His-
tagged human IRF-5 protein spanning residues of
65 amino acids into a pRSET vector (Invitrogen)
(His-IRF-5
192-256 in NCBI accession No. AAU 12877
which corresponds to His-IRF-5
176-240 in NCBI
accession No. NP_116032.1). This is a region which
is located between a DNA-binding domain and an
IRF-association domain. It seems to be the least
homologous with IRF-3 and IRF-7. cDNA of
human peripheral blood mononuclear cells wereIRF-5 mAb Production and Its Karyopherin Binding Properties
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amplified by PCR using the sense primer 5’-GCT
TGCGGATCCCCGCCCACTCTG-3’, and the anti-
sense primer 5’-AGACTGGAATTCTAGATCAGC
AGGTCTGG-3’. The restriction enzyme sites BamHI
and EcoRI are underlined, respectively. The con-
struct was confirmed by DNA sequencing (Applied
Biosystems). The protein was produced in E. coli
BL21(DE3) pLysS (Novagen) containing ampicillin
(50 g/mL) at 37 μ C. Isopropyl- -D-1-thiogalacto β -
pyranoside (IPTG) was added to a final concen-
tration of 0.5 mM when the OD 600 of the culture
broth had reached 0.5 - 0.6. The cells were har-
vested after 4 hours. The cell pellet was resus-
pended in 100 mL of lysis buffer (20 mM Tris, 1
mM DTT, 10% glycerol, 1 mM EDTA, pH 8.0). The
bacterial lysis was sonicated with a Sonosmasher
followed by centrifugation. The supernatant was
loaded onto a Ni
++-NTA agarose resin (Peptron,
Daejeon, Korea) which was equilibrated with a
binding buffer (20mM Tris pH 8.0, 5mM imidazole,
0.5 M NaCl). The bound protein was washed with
a washing buffer (20 mM Tris pH 8.0, 0.5 M NaCl,
20 mM imidazole) and eluted with an elution
buffer (20 mM Tris pH 8.0, 0.5 M NaCl, 200 mM
imidazole). For further purification of the protein,
the eluent was concentrated with centricon
(Vivaspin 20, VS2011) and applied to Sephacryl
S200 gel chromatography (Amersham Biosciences,
Uppsala, Sweden). The purity of the His-IRF-5
193-257
protein was more than 90% using SDS-PAGE. The
molecular weight was measured using MALDI-
TOF (Applied Biosystems).
MAb production and purification
BALB/c mice were intraperitoneally immunized
with 20 g of His-IRF-5 μ
193-257 protein, which was
emulsified in complete Freund's adjuvant and
boosted twice with incomplete Freund's adjuvant
at two week intervals. Finally, the mice were intra-
venously injected with 50 g of His-IRF-5 μ
193-257
protein three days before the fusion. Splenocytes
were fused with P3-X63-Ag8.653 cells and selected
with HAT medium (Sigma-Aldrich Co., St. Louis,
MO, USA). The resulting hybridoma supernatants
were screened using ELISA, as described below.
The isotype of each mAb was determined using
a mouse-hybridoma subtyping kit (Roche). The
colonies which secreted anti-IRF-5 antibodies were
cloned with limited dilution. The three hybridoma
clones, 5IRF8, 5IRF10, and 5IRF24, were purified
for further characterization using a protein G-
Sepharose affinity column (Amersham).
ELISA
Microtiter plates (Corning Inc., Corning, NY,
USA) were coated with 1 g/mL of His-IRF-5 μ
193-
257 for mAb screening. The plates were washed
with 0.05% Tween 20 in PBS (PBST) and blocked
with 5% normal goat serum (NGS) in PBST.
Hybridoma culture supernatants were added to
the plates. The plates were then incubated for 1.5
hours at 37 C. After washing, horseradish perox-
idase (HRP) labeled goat anti-mouse Ig (Sigma)
was added. After 1 hour of incubation, o-pheny-
lenediamine was added to the plates for color
development. The ODs were measured at 490 nm.
Western blot analysis
Whole cell lysates (WCLs) from different cell
lines were prepared using 1% Nonidet P-40 buffer
which contained a protease inhibitor cocktail
(Sigma). The protein concentrations were measured
using a Bradford assay (Biorad) for the analysis of
the WCLs. They were then electrophoresed in 10%
SDS-PAGE. The proteins were transferred to a
nitrocellulose membrane and probed with mAbs
after blocking. HRP-conjugated rabbit anti-mouse
Ig (Sigma) was used as a secondary antibody. The
probe signals were revealed with enhanced chemi-
luminescence (ECL, Labfrontier Co., Seoul, Korea).
Mouse anti-HA and anti-Flag M2 (Sigma) were
used to detect the corresponding tag proteins.
Immunoprecipitation
Cells were lysed with a protease inhibitor cock-
tail. Cell homogenates were centrifuged at 20,000
g for 20 minutes and precleared by incubation
with protein G-Sepharose (Amersham) at 4°C for
1 hour. The precleared extracts (500 g) were in μ -
cubated with purified mAbs. Protein G-Sepharose
was then added and the samples were incubated
for 1.5 hours at 4°C. Immune complexes were
collected by centrifugation and washed with PBS.
The collected complexes were fractionated usingSoo-In Yeon, et al.
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SDS-PAGE, transferred to membranes, and blotted
with anti-GFP (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA). HRP-conjugated goat anti-
mouse Ig (Sigma) was used to detect the probe
signals.
Immunofluorescence and GFP imaging
To observe the applicability of our mAbs for use
in an immunofluorescence assay, HEK293 cells
which were transfected with an IRF-5-GFP plasmid
were cultured in LabTek II chambers (Nunc). They
were then fixed in 4% paraformaldehyde in PHEM
buffer (60 mM PIPES, 25 mM HEPES, 10 mM
EGTA, 4 mM MgSO4, pH 7.0) for 10 minutes at
room temperature. After fixation, the cells were
washed with PBS and incubated for 3 minutes at
4 C with a HEPES-based permeabilization buffer
containing 300 mM sucrose and 0.2% Triton X-100.
The cells were blocked with 0.2% BSA in PBS for
15 minutes. They were then incubated with anti-
IRF-5 mAbs for 1 hour at room temperature. PE-con-
jugated rabbit anti-mouse Ig (BD Pharmingen) was
added after three washes. The cells were observed
with a BX51 fluorescent microscope (Olympus).
HEK 293 cells transfected with an IRF-5-HA
plasmid were incubated for 24 hours and then
treated with 20nM of okadaic acid (Calbiochem) for
6 hours to investigate the movement of phosphory-
lated IRF-5 using our mAbs, Next, the cells were
stained with 5IRF10 and FITC-conjugated anti-
mouse Ig for tracing the movement of IRF-5 into
the nucleus. The nuclei were stained with DAPI.
The binding of IRF-5 to KAP proteins
GST-KAP fusion proteins- 1, - 2, - 3, - 4, - 5, - 6 ɑ ɑ ɑ ɑ ɑ ɑ ,
and - 1 were produced as previously described for β
the assay involving the KAP protein binding to the
cargo protein.
22 HEK293 cells were transfected with
an HA-tagged IRF-5 plasmid. WCLs were pre-
pared after 24 hours and allowed to bind to
Sepharose 4B-immobilized GST-KAPs- 1, - 2, - 3, ɑ ɑ ɑ
- 4, - 5, - 6, and - 1 at 4°C overnight. Unbound ɑ ɑ ɑ β
proteins were washed. Sepharose-bound proteins
were dissolved in a Laemmli sample buffer,
separated on 12% SDS-PAGE, and subjected to
Western blotting. The membrane was blotted with
5IRF10 mAb and then reblotted with anti-GST to
visualize the amount of Sepharose-immobilized
GST-KAP proteins.
RESULTS
Generation of mAbs and antigen reactivity
Recombinant human His-IRF-5
193-257 protein was
produced in E. coli and purified using an affinity
column for immunogens. This region is located
between a DNA-binding domain and an IRF-asso-
ciation domain. The recombinant His-IRF-5
193-257
Fig. 1. SDS-PAGE and MALDI-TOF mass spectrum of recombinant His-IRF-5
193-257. (A) SDS-PAGE analysis of purified
His-IRF-5
193-257. His-IRF-5
193-257 was eluted with 200 mM imidazole on a Ni
++-NTA agarose resin and purifed by Sephacryl
S-200 gel chromatography. (B) MALDI-TOF mass spectrum analysis of purified His-IRF-5
193-257 protein. The molecular
weight (MW) was determined to be 10728.36 Da using MALDI-TOF mass spectrum. This was very close to the theoretical
MW of 10721.1 Da.
A BIRF-5 mAb Production and Its Karyopherin Binding Properties
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protein was purified and identified using SDS-
PAGE (Fig. 1A). The molecular weight was deter-
mined to be 10728.36 Da using MALDI-TOF mass
spectrum (Fig. 1B). This was very similar to the
theoretical molecular weight of 10721.1 Da, implying
the exact fragment of IRF-5 protein.
We obtained clones of three hybridomas; 5IRF8,
5IRF10, and 5IRF24. The culture supernatants were
tested for their specific antigen-binding capacity
using ELISA. This was done by serially diluting
the culture supernatant (Fig. 2A) or His-IRF-5
193-257
antigen (Fig. 2B) to test whether these mAbs recog-
nize the specific antigen. The serially diluted mAbs
were shown to bind in a dose-dependent manner
at a fixed antigen coating concentration of 1 g/ μ
mL. MAbs also bound to antigen in a dose-depen-
dent manner when the antigen coating concentra-
tion was increased from 0.001 to 10 g/mL. These μ
mAbs demonstrated no binding to irrelevant
protein -synuclein at a concentration of 10 ɑ g/ μ
mL. All isotypes of the mAbs were found to be
IgG1 ( ). κ
Western blot analysis
We next tested the reactivity of our mAbs to
His-IRF-5
193-257 protein using Western blot analysis
to determine the antigen reactivity. All three mAbs
Fig. 3. Western blot analysis for antigen specificity. (A) An HA-tagged IRF-5 plasmid was transfected into HEK293 cells
and the WCL was separated. The reactivity of mAbs to IRF-5 was tested. The expression of IRF-5 was tested with anti-HA.
Mouse immune serum was used as a positive control Ab. (B) Detection of endogenous IRF-5. WCLs of THP-1 and NIH3T3
cells were separated and immunoblotted with 5IRF10 as a representative study. NIH3T3 cell lysate was used as a negative
control.
Fig. 2. Binding curve between the anti-IRF-5 monoclonal antibodies and the His-IRF-5
193-257 protein. (A) ELISA was
performed to the wells. The wells were coated with 1 g/mL of His-IRF-5 μ
193-257 protein using the various dilutions of
culture supernatants of our three mAbs. (B) ELISA was performed with mAbs at a fixed dilution to the wells which
were coated with various concentrations of the His-IRF-5
193-257 protein. The bindings of all three mAbs to the control
protein of -synuclein are shown inside the black triangle. ɑ
A
A B
BSoo-In Yeon, et al.
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detected the purified His-IRF-5
193-257 protein (data
not shown). HEK293 cells were transfected with an
HA-tagged IRF-5 plasmid, and WCLs were har-
vested to determine whether these mAbs could
recognize the wild type IRF-5 protein. All three
mAbs readily recognized the wild type IRF-5 and
did not bind to non-transfected control WCLs (Fig.
3A). IRF-5 is constitutively expressed by B cells,
monocytes, and dendritic cells.
10,23 We tested the
binding of 5IRF10 as a representative to the endo-
genous IRF-5 using WCLs of human cell lines of
THP-1 cells. 5IRF10 recognized two major IRF-5
bands at ~61 kDa (Fig. 3B).
Cross-reactivity analysis
The spanning region of recombinant His-IRF-
5
193-257 protein was chosen because it has a very low
amino acid homology with human IRF-3 and
IRF-7. In order to exclude cross-reactivity with
other proteins in the IRF family, we determined
the binding specificity of all three mAbs to IRF-3
and IRF-7. For this study, HEK293 cells were
transfected with each plasmid containing IRF-3,
IRF-5, and IRF-7. The WCL proteins were separated
using SDS-PAGE and immunoblotted with each
mAb. This was followed by reblotting with anti-
HA for IRF-3 and IRF-5, and with anti-Flag for
IRF-7. All three mAbs showed specific binding to
IRF-5 protein, but not to IRF-3 and IRF-7 proteins.
This indicates that our mAbs bind specifically to
IRF-5. We used 5IRF10 data as a representative
(Fig. 4).
Immunofluorescent analysis
Using immunofluorescent staining, three mAbs
were examined for their ability to detect intracel-
lular IRF-5 protein. HEK293 cells, which do not
express the detectable endogenous IRF-5 through
Western blotting (Fig. 4), were transfected with an
IRF-5-GFP plasmid. Indirect immunofluorescent
staining was also performed to observe the location
of the IRF-5. This was done using each mAb and
PE-conjugated anti-mouse Ig as the primary and
secondary antibodies, respectively. Green fluor-
escence was observed in the cytoplasm in an
unstimulated state. IRF-5 protein stained inten-
sively in the cytoplasm with all three mAbs (Fig.
5). When the two images were merged, the staining
image of IRF-5 using each mAb was co-localized
to the GFP expression image. This result demon-
strates that our mAbs can be used for the immu-
nofluorescent staining of IRF-5.
Immunoprecipitation
HEK293 cells were transfected with an IRF-5-
GFP plasmid, and the WCLs were subjected to
immunoprecipitation using our mAbs to identify
the applicability of these mAbs to the immunopre
cipitation procedure. The WCLs were immuno-
precipitated with 5IRF10 mAb as a representative
sample. The precipitates were analyzed with a
Western blot using anti-GFP. IRF-5-GFP protein
was observed at the expected molecular weight of
~88 kDa (Fig. 6A). The immunoprecipitation study
was also performed against WCLs of THP-1 cells
to determine whether 5IRF10 can immunopre-
cipitate endogenous IRF-5 protein. The membrane
was probed with anti-GFP. 5IRF10 could immuno-
precipitate endogenous IRF-5 protein (Fig. 6B).
Import of phosphorylated IRF-5 into the nucleus
The nuclear import study of IRF-5 was perfor-
med to further evaluate the functions of our mAbs.
The movement of phosphorylated IRF-5 was
detected after transfection. To do this, HEK 293
cells were transfected with an HA-IRF-5 plasmid,
stained with 5IRF10. Okadaic acid is a type 1/2A
Fig. 4. Cross-reactive binding study. HA-tagged IRF-3,
HA-tagged IRF-5, and Flag-tagged IRF-7 plasmids were
transfected into HEK293 cells. WCLs were separated
and the cross-reactivity of 5IRF10 to IRF-3 and IRF-7
was tested as a representative study. The membranes
were reblotted with anti-HA or anti-Flag depending on
the tagged protein. Arrow: IRF-5.IRF-5 mAb Production and Its Karyopherin Binding Properties
Yonsei Med J Vol. 49, No. 6, 2008
protein phosphatase inhibitor
24 for forcibly in-
ducing phosphorylation of proteins. Okadaic acid
was used at a low concentration of 20 nM for 6
hours to block entry into and the cell cycle.
25 IRF-5
was located in the cytoplasm in an unstimulated
state and then moved to the nucleus after phos-
phorylation (Fig. 7A). This confirms the results
from a previous report.
10
The KAP family proteins serve important func-
tions as shuttling receptors. They bind to the NLS
motifs of cargo proteins to facilitate their move-
ment into the nucleus.
20 We produced the GST-
KAPs- 1, - 2, - 3, - 4, - 5, - 6, and - 1 in α α α α α α β E. coli
in order to investigate which KAP protein binds
to IRF-5 to facilitate the transport of IRF-5 into the
nucleus. WCLs were prepared from HEK 293 cells,
Fig. 5. Immunofluorescence staining of IRF-5. HEK293
cells were transfected with a GFP-tagged IRF-5 plasmid.
The cells were fixed and stained with the indicated mAbs
for the His-IRF-5
193-257 protein. PE-labeded anti-mouse Ig
was added to the cells. The merged images are shown.
Bar: 10 m. μ
Fig. 7. Import of phosphorylated IRF-5 to the nucleus. (A) The localization of phosphorylated IRF-5 to the nucleus.
HEK293T cells and RAW264.7 cells were transfected with an IRF-5 plasmid and treated with 20 nM OA for 6 h after
transfection. The cells were stained with 5IRF10, followed by FITC-conjugated anti-mouse Ig. DAPI was used for staining
the nucleus. Bar: 10 m. (B) The binding of IRF-5 to KAP- 1 and - 1. GST-KAPs- 1, - 2, - 3, - 4, - 5, - 6 and - 1 fusion μ α β α α α α α α β
proteins immobilized on glutathione-Sepharose 4B beads were incubated overnight at 4°C with WCLs of HEK293 cells
transfected with an IRF-5 plasmid. Sepharose-bound proteins were separated and the membrane was blotted with 5IRF10.
It was then reblotted with anti-GST.
Fig. 6. Immunoprecipitation. (A) HEK293 cells were transfected with a GFP-tagged IRF-5 plasmid. The WCL was immu-
noprecipitated with 5IRF10. The bound proteins were separated and the membrane was blotted with anti-GFP. WCLs
were used as controls (lanes 1 and 3). (B) Immunoprecipitation of endogenous IRF-5 protein. WCLs of human cell lines
of THP-1 and HEK293 were immunoprecipitated with 5IRF10. They were separated and blotted with 5IRF24. HEK293
cell lysate was used as a negative control.
A B
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which were transfected with HA-tagged IRF-5
plasmids, for an in vitro protein-protein interaction
study. The WCLs were incubated overnight with
Sepharose-immobilized GST-KAPs- 1, - 2, - 3, - 4, ɑ α α α
- 5, - 6, and - 1 at 4 α α β C. Sepharose-bound proteins
were analysed using a Western blot. The mem-
brane was blotted with 5IRF10. It was then reblotted
with anti-GST to visualize the amount of Sepharose-
immobilized GST-KAP proteins in the sample. We
identified that KAP- 1 and - 1 were involved in α β
the transport of the IRF-5 protein (Fig. 7B).
DISCUSSION
The His-IRF-5
193-257 protein region was selected
to generate IRF-5-specific mAbs for the further
functional study of IRF-5. This region was chosen
because it belongs to a regulatory domain which
has the least amino acid homology with IRF-3 and
IRF-7. We produced three mAbs against human
IRF-5. These mAbs are useful for performing Wes-
tern blots, in addition to immunocytochemical, and
immunoprecipitation analyses. They were very
specific to His-IRF-5
193-257 protein and recognized
the endogenous IRF-5 and did not show cross-
reaction to IRF-3 and IRF-7 proteins. Using an
overexpression study, there are at least nine
reported human IRF-5 variant isoforms. Variants
1 through 6 encode ~61 kDa isoforms. Variants 7
and 8 encode ~47 kDa isoforms. Variant 9 encodes
a ~25 kDa isoform.
17,23 Among these isoforms,
variants 1 through 7, but not variants 8 and 9,
include the IRF-5
193-257 protein region that was used
as an immunogen in this study. In our data, two
major bands at ~61 kDa could be observed by
Western blot using 5IRF10 in whole cell lysates of
THP-1 cells. However, endogenous ~47-kDa protein
could not be found. This may be due to the low
expression of IRF-5 variant 7 since this expression
has only been studied in overexpressed cells.
23
Human IRF-5 has about an 87% homology with
mouse IRF-5. The region which codes for the His-
IRF-5
193-257 protein has a 72% (47/65) amino acid
sequence homology with mouse IRF-5. Using a
Western blot, we observed that 5IRF10 bound to
~61 kDa mouse endogenous IRF-5 using mouse B
cell lymphoma cell line A20.3
26 (data not shown).
Further evaluation is needed to confirm the
cross-reactivity with mouse IRF-5 by transfecting
mouse IRF-5 genes.
IRF-5 is localized to the cytoplasm in an unsti-
mulated state. It is moved to the nucleus by an
inducible phosphorylation, such as a viral infec-
tion.
10,12 It is then relocalized to the cytoplasm in
a CRM1-dependent pathway.
21 The transport of
IRF-3 into the nucleus is mediated by KAP- 3 and α
KAP- 4 α
27 and the transport out of the nucleus is
mediated by a CRM1-dependent pathway. This
study is the first to identify that IRF-5 is bound
to KAP- 1 and - 1 during transport into the α β
nucleus. This result suggests that the import of the
IRF family of proteins into the nucleus has dif-
ferent controls.
The importance of IRF-5 is increasing. It is one
factor in the susceptibility to autoimmune diseases
such as systemic lupus erythematosus
17 and rheu-
matoid arthritis.
28 It functions as a tumor suppres-
sor and in antiviral immunity by inducing IRF-5-
dependent apoptosis of virus-infected cells.
15 IRF-5
also plays an important role in TLR signaling and
in the induction of the proinflammatory cytokines
IL-6 and IL-12.
11 It is involved in Fas-induced
apoptosis.
29 However, many of the downstream
mediators in the IRF-5 pathway need further iden-
tification for the understanding of autoimmune
diseases and host defense mechanisms and these
mAbs may be helpful for the study.
In summary, we developed anti-IRF-5 mAbs for
IRF-5-specific detection. We demonstrated that
KAP- 1 and - 1 are the nuclear carrier proteins for α β
IRF-5.
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